Cited by 133Fatty Acid Research and HealthCholesterol and Lipid MetabolismLipid metabolism and disorders

N-3 fatty acids stimulate intracellular degradation of apoprotein B in rat hepatocytes.

Open access
Wang, H, Chen, X, Fisher, E A·1993·Journal of Clinical Investigation

Abstract

When rat hepatocytes were incubated with albumin complexed to the n-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), rather than to oleic acid (OA), the secretion of newly synthesized apoprotein B100 (apoB100) or B48 (apoB48) was reduced, despite stimulation of cellular triglyceride synthesis by all three fatty acids. When pulse-chase studies of apoB synthesis and secretion were performed in the presence of OA, EPA, or DHA, there were no significant changes in the initial synthetic rates of either apoB species. However, during the chase period, the total recovery of labeled apoB100 and apoB48 from the cell and medium was less in the n-3 fatty acid groups, so that by 150 min, approximately half as much labeled apoB was recovered as in the OA group. Overall, the decreased accumulation in medium of labeled apoB in the presence of EPA and DHA could be quantitatively accounted for by increased degradation of intracellular apoB. Thus, in the primary hepatocyte, apoB degradation is not constitutive, but can be regulated by n-3 fatty acids.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci116340

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Omega-3 fatty acids lead to intracellular degradation of apo B, thereby diminishing VLDL assembly and decreasing VLDL secretion.

    “In addition, n-3 FAs lead to intracellular degradation of apo B, which may be a result of decreased triglyceride availability or autophagic destruction of apo B via post-Golgi oxidation, 90 thereby diminishing the assembly of VLDL particles in the hepatocyte and decreasing VLDL secretion.91,92”

    From Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association (2019) · cites this paper as [92]

    The Abstract and the discussion on p. 1387 report that EPA and DHA increased intracellular apoB degradation in rat hepatocytes, accounting for decreased secretion of newly synthesized apoB. The paper does not establish that degradation thereby diminishes VLDL assembly; on p. 1387 it treats interference with assembly as a possible cause of apoB degradation, rather than a demonstrated consequence. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Stanbury, J. B., J. B. Wyngaarden, D. S. Fredrickson, J. L. Goldstein, and M. S. Brown. 1983. The Metabolic Basis ofInherited Disease. McGraw Hill, Inc., New York. 597-605.

Cited by

Sorted by citations

Authors
Wang, H., Chen, X., & Fisher, E. A.
Venue
Journal of Clinical Investigation
Published
1993-04-01
Volume
91
Issue
4
Pages
1380-1389
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2125790654
Cited by
133
References
44
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 1 · 2016: 1 · 2015: 3 · 2014: 1 · 2013: 5 · 2012: 7
FWCI
12.10
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • W. W. Smith Charitable Trust
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (HL22633, P01HL022633)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
omega-3 fatty acids, eicosapentaenoic acid, docosahexaenoic acid, oleic acid, apolipoprotein B-100, apolipoprotein B-48, intracellular protein degradation, hepatocytes, triglyceride synthesis, lipoprotein secretion
MeSH terms
Animals, Apolipoproteins B, Cells, Cultured, Chemistry, Physical, Cycloheximide, Docosahexaenoic Acids, Kinetics, Liver, Precipitin Tests, Protein Denaturation, RNA, Messenger, Eicosapentaenoic Acid, Fatty Acids, Omega-3, Rats, Chemical Phenomena

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review